Background Medical abortion became an alternative method of pregnancy termination
following the development of prostaglandins and antiprogesterone in the 1970s and 1980s …

BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

Background Clinical trials have established the high effectiveness and safety of medication
abortion in clinical settings. However, barriers to clinical abortion care have shifted most …

OBJECTIVE: To estimate the effectiveness and acceptability of telemedicine provision of
early medical abortion compared with provision with a face-to-face physician visit at a …

Objective This guideline reviews the evidence relating to the provision of first-trimester
medical induced abortion, including patient eligibility, counselling, and consent; evidence …

OBJECTIVE: To estimate the efficacy and acceptability of medical abortion at 64–70 days
from last menstrual period (LMP) and to compare it with the already proven 57–63 days from …

Background A wide range of drugs have been studied for first trimester medical abortion.
Studies evaluating different regimens, including combination mifepristone and misoprostol …

Background Medical abortion with mifepristone and prostaglandins is well established. We
compared clinical assessment with self-assessment of abortion outcome. Methods This …

OBJECTIVE: To examine the effect of the interval between mifepristone and misoprostol
administration on induction time (first misoprostol dose to abortion), total procedure time …

Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …